Palantir's NHS Contract Sparks Protests Over Data Privacy and Political Concerns

Protesters Demand Palantir's Removal From NHS

On a rainy Thursday morning in Manchester, 80 protesters gathered outside the NHS ConfedExpo to voice opposition to the UK government's contract with Palantir, the American software firm. The group, organized by activist organization Pull the Plug, wore hospital gowns and carried signs reading “Patients vs. Palantir,” demanding that the National Health Service sever ties with the company over serious concerns regarding data privacy, national security, and political affiliations.

At 8 a.m. local time, protesters encircled the conference entrance, calling for immediate action from NHS leadership. Their central concern was the $440 million contract between Palantir and the UK's National Health Service—a deal that is set to run through 2031 but includes a break clause allowing the government to terminate it as early as February 2027.

"Palantir should be kicked out of the NHS, forthwith," said one protester who identified himself as an NHS nurse. "That's the message we want to send to the government and NHS management."

The demonstration was supported by several prominent organizations including Amnesty International and Unison, a union representing healthcare workers. Frieda Lurken, cofounder of Pull the Plug, led chants emphasizing public participation in AI policy and the risks of unchecked technology deployment.

History of Palantir's Involvement With UK Public Sector

The relationship between Palantir and the UK government began in 2020 during the height of the COVID-19 pandemic. At that time, the company was contracted to help track and analyze the spread of the virus through public health systems. Since then, Palantir has won a number of contracts with various public bodies, including the NHS.

The company's current platform—known as the federated data platform—is designed to aggregate information across multiple NHS units, aiming to improve efficiency and reduce wait times. It is used by approximately 65% of local NHS units, according to data from England's NHS Digital Technology Division, with some reporting significant benefits.

However, concerns have grown over Palantir's broader role in the UK's digital infrastructure. A parliamentary report released in early June warned that reliance on Palantir represents “an unacceptable point of weakness” and creates a situation where a foreign company could gain disproportionate control over critical public services.

Controversial Political Affiliations

The controversy deepened after statements made by Palantir cofounder Peter Thiel in 2023, when he suggested that the UK should “rip the whole [NHS] from the ground and start over.” This comment, along with other public remarks by CEO Alex Karp, prompted questions about the company's alignment with conservative political ideologies.

Additionally, Palantir's ties to controversial sectors such as U.S. Immigration and Customs Enforcement (ICE) and Israeli military intelligence have further fueled public outrage. Some protesters at the demonstration carried Palestinian flags, underscoring opposition to what they see as Palantir's role in global surveillance networks.

"It's exactly the use case that you don't outsource, and you certainly don't outsource outside the country," said Laura Gilbert, senior director of AI at the Tony Blair Institute. "We should be learning from that data and building a better health service, not allowing an offshore company to learn and build better products they can sell to someone else."

Palantir Defends Its Role in UK Health Sector

In response to mounting criticism, Palantir has consistently maintained its position that it is politically neutral. Louis Mosley, head of European business at Palantir, stated in a recent interview that the company “doesn't represent party politics” and holds a diverse range of political views internally.

Palantir's internal stance also emphasizes strict adherence to data governance principles. According to Mosley, each NHS trust maintains full control over its own data, and Palantir is strictly prohibited from using or moving it. The company has also pointed to measurable improvements in healthcare outcomes, such as an estimated 110,000 additional operations performed and a 15% reduction in discharge delays.

Stephen Childs, UK head of health partnerships at Palantir, said the software is playing a critical role in improving patient care. "We are helping to deliver better patient care—including almost 800,000 patients removed from waiting lists and a 6.8 per cent increase in cancer diagnosis times," he claimed.

Government Review Underway

In light of the parliamentary report, the UK government is currently reviewing every aspect of the Palantir-NHS contract. Technology Secretary Liz Kendall confirmed that officials are assessing whether to proceed with the agreement as scheduled.

This scrutiny has led to legal action from Palantir itself. According to The Times, the company is preparing to sue London Mayor Sadiq Khan over his decision to block a $65 million deal with the Metropolitan Police, citing ethical concerns related to procurement and values.

Although many of the demonstrators withdrew to a nearby café shortly after the protest began, their voices reflect broader anxieties within the public about the risks of privatizing essential services through foreign technology firms.

Concerns About Patient Trust and Data Integrity

Despite the company's assertions, some healthcare professionals worry that Palantir's notoriety could have unintended consequences for patient care. One protester, identified as JJ, a practicing NHS worker, feared that increased public scrutiny of the company might deter patients from fully disclosing health information.

"We know that people don't want to tell us everything. People are already distrustful. They're just going to clam up," said JJ. "We're going to get less information, less history to be able to help people."

The issue highlights a growing tension in the healthcare sector: how to balance data-driven innovation with patient privacy and trust. The government's decision on whether to maintain or end its contract with Palantir will not only shape the future of digital health in the UK but may also set a precedent for similar deals internationally.

Conclusion: A Critical Crossroads

The ongoing debate over Palantir's involvement in the NHS underscores fundamental questions about data sovereignty, ethical technology use, and democratic accountability. As governments worldwide continue to embrace AI-powered solutions, this case serves as a stark reminder of the importance of public oversight and transparency in the deployment of such systems.

While Palantir claims its tools are helping improve patient outcomes, critics argue that the potential risks—especially in terms of data misuse and political alignment—far outweigh any perceived benefits. Whether the UK government will choose to act on these concerns or continue to support the current arrangement remains an open question, one that will undoubtedly influence the direction of public healthcare technology globally.